ES476385A1 - Un procedimiento para preparar derivados de transpirindina - Google Patents

Un procedimiento para preparar derivados de transpirindina

Info

Publication number
ES476385A1
ES476385A1 ES476385A ES476385A ES476385A1 ES 476385 A1 ES476385 A1 ES 476385A1 ES 476385 A ES476385 A ES 476385A ES 476385 A ES476385 A ES 476385A ES 476385 A1 ES476385 A1 ES 476385A1
Authority
ES
Spain
Prior art keywords
hydrogen
pyrindines
chem
alkyl
except
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES476385A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES476385A1 publication Critical patent/ES476385A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un procedimiento para preparar derivados de transpirindina de fórmula general **fórmula** en donde R''1 es hidrógeno, alquilo de 1 a 8 átomos de carbono, CH2R''3¿o --(CH2)n-(X)m **fórmula**; en la cual : R3 es alquenilo de 2 a 7 átomos de carabono, cicloalquilo de 3 a 6 átomos de carbono, furilo o tetrahidrofurilo; R4 y R5 independientemente son hidrógenos, alquilo de 1 a 3 átomos de carbono, o halógeno ; n es 0, 1, 2 ó 3; m es 0 ó 1, excepto que cuando m es 0, n es diferente de O; X CO, CHOH, CH=CH; SA u O, excepto que cuando n es O, X es diferente de S u O; R2 es hidrógeno , hidroxi, alcoxi de 1 a 3 átomos de carbono o alcanoiloxi de 1 a 3 átomos de carbono ; y sus sales de adición de ácido farmacéuticamente aceptables; cuyo procedimiento comprende: a)hacer reaccionar un compuesto de fórmula general ** fórmula** en donde : R1 es hidrógeno , alquilo de 1 a 8 átomos de carbono, **Fórmulas** R''3 es cicloalquilo de 3 a 6 átomos de carbono, furilo o tetrahidrofurilo; R4 y R5 independientemete son hidrógeno , alquilo de 1 a 3 átomos de carbono, o halógeno; n es , 1, 2 ó 3; m es ó 1 excepto que cuando m es , es diferente a , X es CO, CHOH, CH=CH, S u O, excepto que cuando n es , X es diferente de S u O; R2 es hidrógeno , hidroxi, alcoxi de 1 a 3 átomos de carbono o alcanoliloxi de 1 a 3 átomos de carbono; con hidrógeno y óxido de platino; B) si se desea y cuando R1 es hidrógeno, someter a reacción de alquilación el producto de la etapa anterior; c) opcionalmente , convertir los grupos R2 en otros grupos R2 comprendididos dentro de las definiciones y, si se desea, formar las sales de ácidos farmacéuticamente aceptables de los compuestos obtenidos.
ES476385A 1977-12-27 1978-12-27 Un procedimiento para preparar derivados de transpirindina Expired ES476385A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86489977A 1977-12-27 1977-12-27

Publications (1)

Publication Number Publication Date
ES476385A1 true ES476385A1 (es) 1979-11-16

Family

ID=25344312

Family Applications (1)

Application Number Title Priority Date Filing Date
ES476385A Expired ES476385A1 (es) 1977-12-27 1978-12-27 Un procedimiento para preparar derivados de transpirindina

Country Status (24)

Country Link
EP (1) EP0002937A1 (es)
JP (1) JPS5498770A (es)
AR (1) AR221352A1 (es)
AU (1) AU4286678A (es)
BE (1) BE872990A (es)
BG (1) BG30927A3 (es)
CA (1) CA1105026A (es)
CS (1) CS203940B2 (es)
DD (1) DD141156A5 (es)
DK (1) DK577078A (es)
ES (1) ES476385A1 (es)
FI (1) FI783992A (es)
FR (1) FR2413370A1 (es)
GB (1) GB2010806A (es)
GR (1) GR70349B (es)
IL (1) IL56268A0 (es)
IT (1) IT1101682B (es)
LU (1) LU80719A1 (es)
NZ (1) NZ189230A (es)
PL (1) PL117572B1 (es)
PT (1) PT68934A (es)
RO (1) RO75805A (es)
SU (1) SU841586A3 (es)
ZA (1) ZA787156B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415736A (en) * 1981-12-28 1983-11-15 E. I. Du Pont De Nemours & Co. Certain tetrahydropyridine intermediates
US4579952A (en) * 1981-12-28 1986-04-01 E. I. Du Pont De Nemours And Company Intermediates for octahydrobenzofuro[3,2-e]isoquinolines
US4537963A (en) * 1981-12-28 1985-08-27 E. I. Du Pont De Nemours And Company Intermediates for octahydrobenzofuro[3,2-E]isoquinolines
FR2617481B1 (fr) * 1987-07-03 1989-11-10 Roussel Uclaf Nouveaux derives de la tetrahydropyridine, leur procede de preparation et les intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
WO2011140425A1 (en) 2010-05-06 2011-11-10 Vertex Pharmaceuticals Incorporated Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
AR085893A1 (es) 2011-02-02 2013-11-06 Vertex Pharma Pirrolopirazina-amidas de piperidina espirociclica como moduladores de los canales ionicos
CA2827311A1 (en) 2011-02-18 2012-08-23 Vertex Pharmaceuticals Incorporated Chroman-spirocyclic piperidine amides as modulators of ion channels
EP2686325B1 (en) 2011-03-14 2016-12-14 Vertex Pharmaceuticals Incorporated Morpholine-spirocyclic piperidine amides as modulators of ion channels
ES2780699T3 (es) * 2013-07-10 2020-08-26 Vertex Pharma Amidas de piperidina fusionadas útiles como moduladores de canales iónicos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1024149A (en) * 1972-07-20 1978-01-10 E.I. Du Pont De Nemours And Company 4.alpha.-ARYL-TRANS-DECAHYDROISOQUINOLINES
ZA734895B (en) * 1972-07-20 1974-06-26 Du Pont Analgesigs and/or narcotic antagonists
PT67194B (en) * 1976-11-02 1979-03-23 Lilly Co Eli Process for preparing 4a-aryl-octahydro-1h-2-pyrindines

Also Published As

Publication number Publication date
JPS5498770A (en) 1979-08-03
NZ189230A (en) 1981-05-15
BG30927A3 (en) 1981-09-15
AR221352A1 (es) 1981-01-30
FI783992A (fi) 1979-06-28
IL56268A0 (en) 1979-03-12
PL211919A1 (pl) 1979-09-10
AU4286678A (en) 1979-07-05
CA1105026A (en) 1981-07-14
GB2010806A (en) 1979-07-04
ZA787156B (en) 1980-08-27
BE872990A (fr) 1979-06-22
GR70349B (es) 1982-09-23
PT68934A (en) 1979-01-01
DD141156A5 (de) 1980-04-16
IT1101682B (it) 1985-10-07
CS203940B2 (en) 1981-03-31
RO75805A (ro) 1981-02-28
EP0002937A1 (en) 1979-07-11
SU841586A3 (ru) 1981-06-23
LU80719A1 (fr) 1979-04-13
DK577078A (da) 1979-06-28
IT7831268A0 (it) 1978-12-22
PL117572B1 (en) 1981-08-31
FR2413370A1 (fr) 1979-07-27

Similar Documents

Publication Publication Date Title
ES8301962A1 (es) Un procedimiento para la produccion de un derivado de carboslivilo.
ES455804A1 (es) Un procedimiento de preparacion de nuevos derivados del aci-do 3-quinolein- carboxilico.
JPS57146777A (en) Manufacture of 2-penem compounds, novel compounds manufactured thereby and pharmaceutic compositions containing them
JPS5513278A (en) Benzomorphane compound and medical compound containing it
ES462006A1 (es) Procedimiento para la obtencion de nuevas feniletilaminas.
ES476385A1 (es) Un procedimiento para preparar derivados de transpirindina
ES482472A1 (es) Procedimiento para la preparacion de isoquinoleinas.
SE8903226L (sv) Kemiska foereningar
ES473925A1 (es) Un procedimiento para la preparacion de un oligopeptido
ES386345A1 (es) Procedimiento para la preparacion de compuestos de nafti- lalcohilamina.
IE43847L (en) N-substituted phenylpiperidine derivatives.
IE43662L (en) 3-alkoxy-benzo-1,2,4-triazines
ES8308543A1 (es) "procedimiento para la preparacion de nuevas 2-fenil-2-(piridiloxi)-etilaminas sustituidas".
ES461598A1 (es) Procedimiento para la preparacion de n-cicloalcohilmetil-2- fenilamino-imidazolinas-(2).
ES463783A1 (es) Un procedimiento para la preparacion de cis-4a-aril-octahi- dro-1h-2-pirindinas 2-sustituidas.
ES461785A1 (es) Un metodo para la preparacion de un ester de acido behenico.
ES476168A1 (es) Procedimiento para la preparacion de nuevas imidazo-isoquinoleindionas.
ES8207141A1 (es) Un procedimiento de preparacion de nuevos derivados de la hidroxifenil-tetrahidropiridina .
ES443536A1 (es) Procedimiento para la obtencion de composiciones herbicidas.
ES8406431A1 (es) Procedimiento para preparar derivados de pleuromutilina
ES8105981A1 (es) Procedimiento para la preparacion de derivados de 4-(nafta- leniloxi)piperidina
ES472408A1 (es) Procedimiento para la preparacion de nuevos 2'- hidroxi-2-(5-isoxazolimetil)-6,7-benzomorfanos.
ES447094A1 (es) Procedimiento de preparacion de nuevos derivados de oxadia- zol.
ES433957A1 (es) Un procedimiento de preparacion de nuevas fenotiazinas.
ATE19629T1 (de) N-substituierte derivate des tetrahydroisophthalimids.